Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Efficacy of OXN PR, Compared to Oxy PR, for Reduction of Intensity of Opioid-induced Constipation Symptoms in Pts Treated for Cancer or Non-cancer Pain: A Randomised, Double-blind, Controlled, Multicentre Study

NCT01014559 is registered in ClinicalTrials.gov with Mundipharma SAS as lead sponsor.

NCT NCT01014559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01014559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Efficacy of OXN PR, Compared to Oxy PR, for Reduction of Intensity of Opioid-induced Constipation Symptoms in Pts Treated for Cancer or Non-cancer Pain: A Randomised, Double-blind, Controlled, Multicentre Study
Lead sponsor
Mundipharma SAS
Phase
Phase 3
Overall status
Terminated
Start date
February 28, 2010
Completion date
February 28, 2013
Enrollment
225 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation, pain